These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 6712730

  • 1. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS.
    Biochem Pharmacol; 1984 Apr 15; 33(8):1187-94. PubMed ID: 6712730
    [Abstract] [Full Text] [Related]

  • 2. Ammonium inhibition of fatty acid oxidation in rat liver mitochondria. A possible cause of fatty liver in Reye's syndrome and urea cycle defects.
    Maddaiah VT.
    Biochem Biophys Res Commun; 1985 Mar 15; 127(2):565-70. PubMed ID: 3977937
    [Abstract] [Full Text] [Related]

  • 3. Carnitine metabolism in rats with 4-pentenoic acid induced fatty liver.
    Yuge K.
    Acta Paediatr Jpn; 1990 Aug 15; 32(4):449-55. PubMed ID: 2288228
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of L-carnitine supplementation in 4 pentenoic acid treated rats.
    Sugimoto T, Woo M, Nishida N, Araki A, Murakami K, Kobayashi Y.
    Brain Dev; 1990 Aug 15; 12(4):417-22. PubMed ID: 2240462
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
    Deschamps D, Fisch C, Fromenty B, Berson A, Degott C, Pessayre D.
    J Pharmacol Exp Ther; 1991 Nov 15; 259(2):894-904. PubMed ID: 1941634
    [Abstract] [Full Text] [Related]

  • 11. The effect of glucagon treatment and starvation of virgin and lactating rats on the rates of oxidation of octanoyl-L-carnitine and octanoate by isolated liver mitochondria.
    Zammit VA.
    Biochem J; 1980 Aug 15; 190(2):293-300. PubMed ID: 7470052
    [Abstract] [Full Text] [Related]

  • 12. Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters.
    Chase JF, Tubbs PK.
    Biochem J; 1972 Aug 15; 129(1):55-65. PubMed ID: 4646779
    [Abstract] [Full Text] [Related]

  • 13. Some aspects of fatty acid oxidation in isolated fat-cell mitochondria from rat.
    Harper RD, Saggerson ED.
    Biochem J; 1975 Dec 15; 152(3):485-94. PubMed ID: 1227502
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of the free acids and their carnitine esters on coenzyme A-dependent oxidations in rat liver mitochondria.
    Holland PC, Sherratt HS.
    Biochem J; 1973 Sep 15; 136(1):157-71. PubMed ID: 4772622
    [Abstract] [Full Text] [Related]

  • 20. Hepatic metabolic alterations in rats treated with low-dose endotoxin and aspirin: an animal model of Reye's syndrome.
    Kilpatrick LE, Polin RA, Douglas SD, Corkey BE.
    Metabolism; 1989 Jan 15; 38(1):73-7. PubMed ID: 2909830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.